PEUCX
Price
$39.31
Change
+$0.19 (+0.49%)
Updated
Jun 27 closing price
Net Assets
8.65B
RMEBX
Price
$58.73
Change
+$0.13 (+0.22%)
Updated
Jun 27 closing price
Net Assets
107B
Interact to see
Advertisement

PEUCX vs RMEBX

Header iconPEUCX vs RMEBX Comparison
Open Charts PEUCX vs RMEBXBanner chart's image
Principal Equity Income C
Price$39.31
Change+$0.19 (+0.49%)
VolumeN/A
Net Assets8.65B
American Funds American Mutual R2E
Price$58.73
Change+$0.13 (+0.22%)
VolumeN/A
Net Assets107B
PEUCX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PEUCX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEUCX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 107B vs. PEUCX (8.65B). RMEBX pays higher dividends than PEUCX: RMEBX (1.16) vs PEUCX (0.63). PEUCX was incepted earlier than RMEBX: PEUCX (23 years) vs RMEBX (11 years). PEUCX (1.62) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. PEUCX (16.30). RMEBX has a lower initial minimum investment than PEUCX: RMEBX (250) vs PEUCX (1000). RMEBX annual gain was more profitable for investors over the last year : 9.78 vs. PEUCX (2.03). RMEBX return over 5 years is better than : 63.07 vs. PEUCX (48.49).
PEUCXRMEBXPEUCX / RMEBX
Total Expense Ratio1.621.07151%
Annual Report Gross Expense Ratio1.621.07151%
Fund Existence23 years11 years-
Gain YTD4.3287.55357%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.65B107B8%
Annual Yield % from dividends0.631.1654%
Returns for 1 year2.039.7821%
Returns for 3 years17.3927.2964%
Returns for 5 years48.4963.0777%
Returns for 10 years66.3374.6689%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.940.04
+1.55%
Spero Therapeutics
SHG44.320.16
+0.36%
Shinhan Financial Group Co Ltd
AMED97.94-0.09
-0.09%
Amedisys
VIR5.16-0.14
-2.73%
Vir Biotechnology
DFDV16.82-1.13
-6.27%
DeFi Development Corp